Description:PTC-209, with the CAS number 315704-66-6, is a small molecule that has garnered attention in the field of medicinal chemistry, particularly for its role as a selective inhibitor of the protein p53. This compound is known for its potential therapeutic applications, particularly in cancer treatment, as it modulates the activity of p53, a crucial tumor suppressor protein involved in regulating the cell cycle and apoptosis. PTC-209 has been studied for its ability to enhance the efficacy of certain chemotherapeutic agents and to induce apoptosis in cancer cells. The compound is characterized by its specific binding affinity to p53, which allows it to exert its effects selectively. Additionally, PTC-209's chemical structure includes various functional groups that contribute to its biological activity and solubility properties. Ongoing research continues to explore its pharmacokinetics, safety profile, and potential applications in combination therapies for various malignancies.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![N-(2,6-Dibromo-4-Methoxyphenyl)-4-(2-Methylimidazolo[1,2-A]Pyrimidin-3-Yl)-2-Thiazolamide](https://static.cymitquimica.com/products/54/thumb/OR1023738.jpg)
